Intraluminal prostaglandin E2 affects gallbladder function by activation of intramural nerves in the anaesthetized cat.
Gallbladder mucosal net fluid transport and motility were measured in vivo by a continuous perfusion technique in the anaesthetized cat. Prostaglandin E2, administered to the perfused gallbladder lumen, caused a contraction decreasing gallbladder volume capacity, and induced a secretory response by the mucosa. These effects by prostaglandin E2 were abolished by the nerve-blocking agent tetrodotoxin (administered close intraarterially) and somatostatin (administered intravenously), but not by intravenous hexamethonium. Atropine (administered intravenously) reduced the order of magnitude of the gallbladder contraction in response to prostaglandin E2 but did not affect the secretory response by the mucosa. Neither of these drugs significantly affected gallbladder volume capacity or mucosal fluid transport during basal conditions. Tetrodotoxin did not abolish the gallbladder responses to intravenous cholecystokinin or vasoactive intestinal peptide, peptides known to act directly upon smooth muscle and epithelial cell receptors, respectively. It is suggested that prostaglandin E2 affects gallbladder function in vivo mainly by activation of postganglionic non-cholinergic intramural nerve cells.
Jivegård
L
L
Department of Surgery I, Gothenburg University, Sweden.
Thune
A
A
Svanvik
J
J
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000187:drug effects*; D002415:Cats; D015232:Dinoprostone / Q000008:administration & dosage*; D005704:Gallbladder / Q000187:drug effects* / Q000294:innervation; D009092:Mucous Membrane / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D013004:Somatostatin / Q000494:pharmacology; D014882:Water-Electrolyte Balance / Q000187:drug effects
D013004:Somatostatin; D001285:Atropine; D015232:Dinoprostone